Skip to main content
Veterinary Medicines

CANIGEN CHP LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR CHIENS

Authorised
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Water for injection

Product identification

Medicine name:
CANIGEN CHP LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR CHIENS
Active substance:
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Water for injection
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain Cornell 780916, Live
    1000000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine distemper virus, strain Lederle, Live
    100000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan, Live
    10000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Water for injection
    1.00
    millilitre(s)
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD02
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/4843560 6/1982
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 11/12/2023

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."